Know Cancer

or
forgot password

Phase II Study of Pre-Operative Chemotherapy With Taxol, Cisplatin, and 5-Fluorouracil Followed by G-CSF in Patients With Resectable Local-Regional Carcinoma of Esophagus


Phase 2
18 Years
N/A
Not Enrolling
Both
Esophageal Diseases

Thank you

Trial Information

Phase II Study of Pre-Operative Chemotherapy With Taxol, Cisplatin, and 5-Fluorouracil Followed by G-CSF in Patients With Resectable Local-Regional Carcinoma of Esophagus


This study is designed for patients with resectable, local-regional carcinoma of the
esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and
5-Fluorouracil will be administered followed by G-CSF.


Inclusion Criteria:



- Measurable disease with resectable local-regional carcinoma of the esophagus. 18
years of age or older.

Exclusion Criteria:

- Pregnant or lactating. Non-resectable local-regional carcinoma of the esophagus.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

Michael Fanucchi, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Emory University Winship Cancer Institute

Authority:

United States: Institutional Review Board

Study ID:

0691-1995

NCT ID:

NCT00208936

Start Date:

January 1996

Completion Date:

Related Keywords:

  • Esophageal Diseases
  • Esophageal Diseases
  • Carcinoma
  • Esophageal Diseases
  • Esophageal Neoplasms

Name

Location
Emory University Winship Cancer Institute Atlanta, Georgia  30322